Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeartburn is one of the more commonly reported digestive side effects of Wegovy. Semaglutide slows the rate at which food leaves the stomach, and for some people that slower emptying creates exactly the kind of pressure and acid reflux that feels like heartburn or indigestion. It tends to be most noticeable in the early weeks of treatment or after a dose increase, and it often settles once the body adjusts. It's a prescription-only medicine, so if heartburn becomes persistent or severe, the right step is to go back to your prescribing clinician rather than manage it alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors, which are involved in appetite signalling and blood sugar regulation. One of the effects of that activation is a meaningful reduction in gastric motility, food spends longer in the stomach than it normally would. Most of the time, that's part of why people feel fuller on smaller meals. The downside is that food sitting in the stomach for longer can push stomach acid back up towards the oesophagus, producing the burning sensation most people recognise as heartburn or acid reflux, and you can find a detailed breakdown of exactly how this happens on our page covering Wegovy heartburn, including why some people are more susceptible than others.
This isn't unique to Wegovy. Indigestion, reflux and burping appear in the side-effect profiles of the whole GLP-1 class, and the NHS's patient information for semaglutide lists indigestion and heartburn among the more common effects. The mechanism is straightforward: slower emptying creates more opportunity for acid exposure at the lower oesophageal sphincter, particularly if you eat quickly, eat large portions, or lie down shortly after a meal.
You can read more about the full side-effect picture on the Wegovy side effects overview, which covers the broader gastrointestinal pattern and what typically settles with time versus what should prompt a call to your prescriber.
A question our prescribers hear most weeks is whether heartburn means something has gone wrong with treatment. In the vast majority of cases, it doesn't. The timing follows a clear pattern: symptoms tend to peak in the first one to three weeks after starting a new dose, then gradually reduce as the gut adapts to the slower pace of emptying. If you've moved from 0.5mg to 1.0mg, or from 1.7mg to 2.4mg, a temporary return of heartburn is common and expected.
That said, not everyone experiences it at all. Individual differences in stomach acid production, diet, and whether someone already had a tendency toward reflux before starting treatment all affect how much of a problem it becomes. People with a history of gastro-oesophageal reflux disease (GORD) may find symptoms are more pronounced, and that's worth flagging in your consultation history.
If you're thinking about how heartburn fits into your decision about starting treatment, the Wegovy overview page lays out the broader clinical picture, including how the titration schedule works and what to expect across the first several months.
Several straightforward adjustments tend to reduce how much heartburn you experience during treatment. Eating smaller meals more frequently places less pressure on the stomach than large portions eaten quickly. Avoiding eating within two to three hours of lying down gives acid less opportunity to travel upward. Reducing fatty, fried, spicy or acidic foods during the adjustment period can also help, since these naturally delay gastric emptying even without semaglutide in the picture.
Staying well hydrated matters too, though sipping water steadily works better than drinking large amounts with meals. Propping the head of the bed up slightly (even a couple of inches) is a well-established non-pharmacological approach for people who experience reflux overnight.
If lifestyle adjustments aren't enough, your prescriber can discuss whether an over-the-counter antacid is appropriate, or whether a proton pump inhibitor might be considered. Do not change your dose or pause treatment based on heartburn alone without speaking to your clinician first. More detail on the experience of reflux specifically on semaglutide is covered on the page about bad heartburn on Wegovy, including when it tips from manageable to something needing clinical review.
For context on how Wegovy compares cost-wise with other private weight-loss treatments, the Wegovy price guide sets out what a complete private prescription typically includes. It's one question worth settling early so cost doesn't become a reason to stop treatment midway through.
Mild-to-moderate heartburn that responds to diet changes or settles within a couple of weeks of a dose increase doesn't usually require urgent attention. But there are circumstances where you should contact your GP or prescriber promptly rather than waiting.
Persistent heartburn that does not improve after four to six weeks, heartburn severe enough to affect sleep or eating consistently, or any difficulty swallowing, these all warrant a clinical conversation. More urgently: severe, persistent stomach pain that radiates toward the back, with or without vomiting, is the key warning sign associated with pancreatitis, which is a known but infrequent serious side effect of GLP-1 medicines. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a serious adverse event to be aware of with this class of medicines. Heartburn and pancreatitis feel very different, but it's worth knowing that distinction clearly.
If you're also experiencing vomiting, significant dehydration, or chest pain that doesn't clearly feel like digestive discomfort, get medical advice the same day. Suspected side effects can also be reported through the MHRA's Yellow Card scheme.
The relationship between semaglutide and heartburn has its own dedicated page if you want to dig further into the pharmacology. And if you'd like to discuss how your own history of reflux or digestive health might affect your suitability, a free consultation with one of our clinicians is a good starting point.
At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber. Start your free consultation to talk through whether Wegovy is the right fit for your circumstances.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.